Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MVIR-B.ST
- Price
- -
- Stock movement down
- -0.09 (-1.27%)
- Company name
- Medivir AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 389.96M
- Ent value
- 427.36M
- Price/Sales
- 90.52
- Price/Book
- 2.24
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -34.65%
- 1 year return
- -11.19%
- 3 year return
- -23.05%
- 5 year return
- -27.95%
- 10 year return
- -20.48%
Last updated: 2024-12-17
DIVIDENDS
MVIR-B.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 90.52 |
| Price to Book | 2.24 |
| EV to Sales | 99.20 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 55.72M |
| EPS (TTM) | -1.34 |
| FCF per share (TTM) | -1.42 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.31M |
| Gross profit (TTM) | 4.31M |
| Operating income (TTM) | -74.95M |
| Net income (TTM) | -74.49M |
| EPS (TTM) | -1.34 |
| EPS (1y forward) | -1.61 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -1739.88% |
| Profit margin (TTM) | -1729.18% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.90M |
| Net receivables | 4.90M |
| Total current assets | 105.70M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 216.20M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 29.40M |
| Total liabilities | 42.30M |
| Shareholder's equity | 173.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -78.12M |
| Capital expenditures (TTM) | 800.00K |
| Free cash flow (TTM) | -78.92M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -42.84% |
| Return on Assets | -34.46% |
| Return on Invested Capital | -42.84% |
| Cash Return on Invested Capital | -45.38% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| MVIR-B.ST | S&P500 | |
| Current price drop from All-time high | -98.01% | -5.62% |
| Highest price drop | -98.04% | -56.47% |
| Date of highest drop | 5 Jul 2023 | 9 Mar 2009 |
| Avg drop from high | -79.94% | -11.07% |
| Avg time to new high | 369 days | 12 days |
| Max time to new high | 5877 days | 1805 days |
COMPANY DETAILS
Marketcap
389.96M
Marketcap category
Small-cap
Description
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It is also developing Remetinostat for treating MF cutaneous T-cell lymphoma and basal cell carcinoma, as well as squamous cell carcinoma. In addition, the company is developing MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors, as well as USP-1/TNG348, USP-7, and MBLI/MET-X, which completed preclinical trials for treating cancer and infection. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
Employees
9
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found